scholarly journals Comment on: Prevention of biliary fistula after partial hepatectomy by transcystic biliary drainage: randomized clinical trial

2020 ◽  
Vol 107 (8) ◽  
pp. e285-e285
Author(s):  
S. Akbulut ◽  
T. T. Sahin ◽  
S. Yilmaz
2020 ◽  
Vol 107 (7) ◽  
pp. 824-831 ◽  
Author(s):  
C. Maulat ◽  
J.-M. Regimbeau ◽  
E. Buc ◽  
E. Boleslawski ◽  
J. Belghiti ◽  
...  

Pancreatology ◽  
2018 ◽  
Vol 18 (4) ◽  
pp. S4-S5
Author(s):  
Sohei Satoi ◽  
Yomohisa Yamamoto ◽  
Tsutomu Fujii ◽  
Suguru Yamada ◽  
Hiroaki Yanagimoto ◽  
...  

Open Medicine ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. 815-821
Author(s):  
Alex Zanvettor ◽  
Wolfgang Lederer ◽  
Bernhard Glodny ◽  
Andreas P. Chemelli ◽  
Franz J. Wiedermann

AbstractProcedural sedation and analgesia (PSA) is important during painful dilatation and stenting in patients undergoing percutaneous trans-hepatic biliary drainage (PTBD). A prospective, nonblinded randomized clinical trial was performed comparing different analgesic regimens with regard to the patient’s comfort. Patients were randomly assigned to two treatment groups in a parallel study, receiving either remifentanil or combined midazolam, piritramide, and S-ketamine. The primary study endpoint was pain intensity before, during, and after the intervention using the numerical rating scale (0, no pain; 10, maximum pain). The secondary study endpoint was the satisfaction of the interventional radiologist. Fifty patients underwent PTBD of whom 19 (38.0%) underwent additional stenting. During intervention, the two groups did not differ significantly. After the intervention, the need for auxiliary opioids was higher (12.5% vs 7.7%; p = 0.571) and nausea/vomiting was more frequently observed (33.4% vs 3.8%; p = 0.007) in patients with remifentanil than in patients with PSA. Overall, 45 patients (90.0%) needed additional administration of non-opioid analgesics during postinterventional observation. Remifentanil and combined midazolam, piritramide, and S-ketamine obtained adequate analgesic effects during PTBD. After the intervention, medications with antiemetics and long-acting analgesics were more frequently administered in patients treated with remifentanil (EudraCT No. 2006-003285-34; institutional funding).


2002 ◽  
Vol 89 (2) ◽  
pp. 154-157 ◽  
Author(s):  
F. F Palazzo ◽  
D. L Francis ◽  
M. A Clifton

2001 ◽  
Vol 120 (5) ◽  
pp. A453-A453 ◽  
Author(s):  
B SHEN ◽  
J ACHKAR ◽  
B LASHNER ◽  
A ORMSBY ◽  
F REMZI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document